de Swart L, Reiniers C, Bagguley T, van Marrewijk C, Bowen D, Hellström-Lindberg E, Tatic A, Symeonidis A, Huls G, Cermak J, van de Loosdrecht AA, Garelius H, Culligan D, Macheta M, Spanoudakis M, Panagiotidis P, Krejci M, Blijlevens N, Langemeijer S, Droste J, Swinkels DW, Smith A, de Witte T. Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes. Haematologica [Internet]. 2017Dec.31 [cited 2026Nov.10];103(1):69-. Available from: https://haematologica.org/article/view/8324